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Ameliorative efficacyAbstract This study was conducted to evaluate cognitive enhancing effect and ameliorative effects
of black seed oil in scopolamine induced rat model of cognitive impairment. These effects were
investigated on scopolamine-induced dementia model in Morris water maze test (MWM) and Y
maze test. The hippocampal histoarchitectural responses to scopolamine and Nigella sativa oil were
also examined.
Scopolamine (1 mg/kg ip) was given to induce dementia, followed by oral administration of BSO
(1 ml/kg) for 14 consecutive days. MWM and Y-maze paradigms were used to assess hippocampal
and frontal dependent memory respectively, thereafter the rats were sacrificed and brains were
removed for histopathologic studies.
Scopolamine resulted in memory impairment, by delayed latency in the MWM, reduced percentage
alternation in the Y maze that was coupled by alterations in the cortico-hippocampal neurons. Post-
treatment of rats with BSO mitigated scopolamine-induced amnesia, by reducing latency period and
increasing percentage alternation and histological changes. The observed anti-amnestic effect of
BSO makes it a promising anti-amnesic agent for clinical trials in patients with cognitive impair-
ment.
 2016 Publishing services provided by Elsevier B.V. on behalf of Faculty of Pharmacy, Cairo University.1. Introduction
Dementia is characterized by a loss or decline in memory and
other cognitive functions, and one of the most common sub-
50 A. Imam et al.types of dementia is Alzheimer’s disease (AD).1 AD is charac-
terized by a cascade of conditions like neural oxidative stress,
deposition of amyloid plaques, neurofibrillary tangles, inflam-
mation and impaired central functions.2 The implicated mech-
anism of AD in the elderly sufferers is linked to the loss of
cholinergic neurons in the basal forebrain and hippocampus.3
Scopolamine is a muscarinic receptor antagonist with pro-
found amnesic effects in a variety of learning paradigms and
a useful experimental pharmacological model to investigate
the pathophysiology of the cognitive deficit in AD.4 It has been
widely implicated to cause amnesia and a viable model of
dementia in humans and animals.5–7 Scopolamine caused its
cholinergic deficits via oxidative stress8,9 and neuroinflamma-
tion.10 Scopolamine induced memory deficits have been widely
implicated for the screening of anti-dementia drugs.11,12
The most common treatment modalities for AD symptoms
are the cholinesterase inhibitors, whose primary targets are
AChE and BChE for their therapeutic activities. However,
these agents cause undesirable side effects, thereby limiting
their use. The present therapies produce modest symptomatic
improvements in patients; thus, searching for alternative or
supplement anti-amnesic agent is an ultimate necessity.
Herbal and natural plant extracts have gained wide atten-
tion in their use in the treatment and/or management of neu-
rological, psychiatric and degenerative diseases, due to their
no or less side-effects.13,14 Black seed oil is a high value medic-
inal solvent, widely used traditionally in the treatment of many
diseases. Compelling evidences have reported that black seed
oil (BSO) exhibits protective activities against many diseases
depending on its high antioxidant15 and anti-inflammatory
properties.16 This could suggest its use as a potential remedy
for cognitive impairments in AD.
A number of studies have been carried out, acclaimedmedic-
inal properties emphasized on different pharmacotherapeutical
efficacies of black seed oil such as antioxidative17 and neuropro-
tective,15,18 antiasthmatic,19 anti-inflammatory, immunomodu-
latory and anti-tumor properties,16 gastric ulcer healing,20
tumor growth suppression,21 men infertility improvement,22
and stimulate milk production.23 The main active ingredients
in BSO are thymoquinone (TQ), alkaloids (nigellidine, nigellim-
ine, and nigellicine), vitamins such as thiamine, riboflavin, pyri-
doxine, niacin, and folic acid, minerals, and proteins.24
The present study was designed to investigate the ameliora-
tive efficacy of BSO against behavioral alterations in scopo-
lamine demented rats. Their neuroprotective effects on
cortico-hippocampal neuronal alterations were also evaluated.
2. Materials and methods
2.1. Drugs
Scopolamine hydrobromide (sigma, USA) was used in the pre-
sent study. Scopolamine was dissolved in saline (NaCl 0.9%)
at final concentrations of 1 mg/kg, and was injected intraperi-
toneally. The black seed oil (100% pure natural oil) was
obtained from Masra warda, Kingdom of Saud.
2.2. Experimental animals
Eighteen adult albino Wistar rats weighting 200 ± 20 g at the
time of acquisition and acclimatization were used in this study.They were housed singly in metabolic cages under standard
laboratory conditions in Animal holding of the Faculty of
Basic Medical Sciences, University of Ilorin, Ilorin. They had
free access to food and water, were housed six in a cage, and
kept at controlled temperature (22 ± 2 C) under a 12/12 h
light-dark cycle. All procedures were performed in accordance
with institutional guidelines for animal care and use.
2.3. Treatments schedule
The rats were randomly distributed into four groups (n= 6) as
follows:
A. received saline for 14 days
B. received BSO (1 ml/kg) orally for 14 days
C. received scopolamine (1 mg/kg) intraperitoneally for
14 days
D. BSO (1 ml/kg) orally, 30 min after scopolamine
(1 mg/kg) intraperitoneally for 14 days
All experiments were carried out during the light phase
between 9:00 and 15:00. Experimental groups consisted of 6
animals each.
2.4. Ethical approval
All procedures were performed in accordance with institu-
tional guidelines for animal care and use and ethical approvals
were received the University of Ilorin ethics review committee.2.5. Morris water maze test
Morris water maze is one of the most widely used tasks for
testing spatial learning and memory in rodents and the proce-
dure used in the present experiment was a modification. In this
test, water maze consists of a circular pool (1.6 m diameter and
50 cm height) colored with black nontoxic dye filled to a depth
of 44 cm with water. The temperature in pool was maintained
at 25 ± 1 C. Four equally spaced points around the edge of
the pool were designed as North (N), East (E), South (S)
and West (W). A black colored round platform of 9 cm diam-
eter was placed 1 cm below the surface of water. The rats were
trained to navigate the submerged platform. The rats were
given a maximum time of 120 s (cut-off time) to find the hid-
den platform and were allowed to stay on it for 30 s. The plat-
form remained in the same position during the training days.
Rats that failed to locate the platform within 120 s were put
on the platform only in the first session. The animals were
given a daily session of five trials. Escape latency time to reach
the platform was recorded in each trial.2.6. Y maze
The behavioral test was conducted in a large quite room. Y-
maze apparatus was used to assess the animals’ spatial mem-
ory. A stop watch was used to score the behaviors and all
events were observed manually. A Y-maze is made up of three
equally spaced arms, labeled as A, B, and C which are 120
from each other, 41 cm long and 15 cm high. It was used to
assess the spontaneous alternation in the rats. The floor of
Figure 1 Effects of BSO scopolamine and Scop + BSO on
escape latency (LTM) in the Morris water maze paradigm. Data
presented as mean ± SEM, asterisks (*) indicate significant
(p< 0.05) difference from the scopolamine treated rats.
Figure 2 Effects of BSO scopolamine and Scop + BSO on
escape latency (STM) in the Morris water maze paradigm. Data
presented as mean ± SEM, asterisks (*) indicate significant
(p< 0.05) difference from the scopolamine treated rats.
Scopolamine-induced memory dysfunction and cortico-hippocampal neural alterations 51the apparatus is 5 cm wide and is leveled with saw shaves. Each
rat was stationed in one of the arms and allowed to freely
explore the apparatus. The sequence or consecutive entrance
of the animals into the arms is termed an alternation.
The total number of arms entered minus two is termed
spontaneous alternations, and the percentage alternation was
calculated as {(actual alternations/maximum alternations) 
100}00. 5 min was assigned as the test time limit for each of
the animals in the Y-maze apparatus.
Recorded data is the total arm entries indicate the total
number of a single arm entered (e.g. ABCBCABACBC, con-
tain 11 entries), from which the correct and wrong alternations
are recorded.
2.7. Histopathology
The rats were anesthetized 24 h after the behavioral tests,
decapitated and their brains were excised and stored in 4%
paraformaldehyde preparation. Then, the brains were pro-
cessed for histo-architectural examination, embedded in paraf-
fin, refrigerated, then the brains were sliced coronally into
8 lm sections (from Bregma 2–4 mm of frontal cortex,
2.5 mm to 4.5 mm of the hippocampal formation and
10 mm to 15 mm of the cerebellar cortex) with a rotary
microtome (MK 1110) and the sections were stained with
Hematoxylin and Eosine (H&E) for general cytoarchitecture
and Cresyl fast violet (CFV) for nissl granulation in accor-
dance with routine laboratory procedures (Bancroft & Gam-
ble, 2008). Representative photomicrograph of each section
was produced using an Olympus BX 51 microscope and a
DP 12 digital camera.
2.8. Statistical analysis
In this investigation, the results were expressed as mean
± standard deviation (n= 6). The data from Morris water
maze and Y maze tests were analyzed statistically by one
way analysis of variance (One-way ANOVA) and different
group means were compared by Bonferroni’s test. p< 0.05
was considered statistically significant in all cases. The Graph
Pad Prism was used for analysis and graphical representation
of data.
3. Results
3.1. Cognitive functions
Scopolamine significantly (p< 0.05) impaired hippocampal
and frontal-dependent memory tasks, causing a delayed
latency to find the escape platform in the MWM paradigm
(Fig. 1) and lowered percentage alternation in the Y maze
paradigm. From the first (LTM test) and subsequent (STM
test) exposure to the MWM paradigm, it was observed that
NSO treated rats showed a shorter latency time than saline
and scopolamine treated rats (p< 0.05, Figs. 1 and 2).
The potential effect of BSO as anti-amnesic agent shows
that as a single administration and as intervention following
scopolamine significantly (p< 0.05) reduced the latency to
find the platform (Figs. 1 and 2). Therefore, rats treated with
BSO after scopolamine for 14 days had reversed amnesiainduced by scopolamine. Hence oral administration of
1 ml/kg/b wt of BSO can reverse (p< 0.05) the memory
impairment induced by scopolamine treatment.
Scopolamine also caused a significant (p< 0.05) reduction
in the percentage alternation in the Y maze paradigm, an alter-
nation dependent effect, which was significantly (p< 0.05)
reversed by BSO with increased percentage alternation sug-
gesting its anti-amnesic efficacy against scopolamine induced
amnesia (Fig. 3).
3.2. Histopathological results
Sections of the Frontal cortices (FC) of the animals treated
with scopolamine, specifically the pyramidal cells at the inter-
nal pyramidal cell layer shows some degree of retraction of
processes, vacuolation of the surrounding neuropil of the
Figure 3 Effects of BSO scopolamine and Scop + BSO on %
Alternation (working memory) tasks in the Y maze paradigm.
Data presented as mean ± SEM, asterisks (*) indicate significant
(p< 0.05) difference from the scopolamine and Scop + BSO
treated rats.
52 A. Imam et al.pyramidal cells and hyperchromatic and shrunken perikarya
(Fig. 4). Also corkscrew-shaped apical dendrites and blending
of the membrane into the perikaryal cytoplasm are observed
(Fig. 4). BSO was observed in this study to enhance axonal-
dendritic connections and also reduce the scopolamine induced
vacuolation to nearly normal when compared with the control
(Fig. 4). Scopolamine also caused irregular distributions of
nissl granulation in the perikaryal, increased dark picnotic
nuclei and selective staining of nissl granules (tigroid bodies
and nissl bodies), the presence of dark neuron, glial activation
and dendritic cytoplasms suggesting protein denaturing andFigure 4 Effects of scopolamine, BSO and Scop + BSO on the Fron
the pyramidal neuron, with a well outlined soma and unaffected proje
neuropil of the pyramidal cells, shrunken perikarya and blended me
reduced vacuolation and distinct processes with less blending in the pneural degeneration in the hippocampus, dentate gyrus and
frontal cortex (Figs. 8–11). BSO reversed this pathologies to
almost normal when compared with the control.
The hippocampus is made up of Cornu Ammonis CA1 and
CA2 formed of zone of small pyramidal cells, CA3 and CA4
formed of zone of large pyramidal cells. CA4 projects into
the dentate gyrus, made of small granule cells. The neuronal
processes (axons and dendrites), glial cells and scattered nerve
cells are found in areas between the compact zones of the cells.
BSO was able to repair the damages induced by scopolamine
exposure, including disorganization and loss of small pyrami-
dal cells (CA1), some of which had pale nuclei while others
were dark (Fig. 5). There was also a marked shrinkage in the
size of the large pyramidal cells (CA3), the outer layer was
more affected, with darkened nuclei and clumped processes
(Fig. 6). Some darkened, pyknotic nuclei are observed in the
granular cells of the dentate gyrus with contrasting basophilia
of some other granular cells nuclei, also marked vacuolation
and excess glial cells, effects ameliorated by BSO are observed
(Figs. 7–11).
4. Discussion
Scopolamine has been implicated to impair learning and mem-
ory in human and rats, as such it is considered to be a good
model of AD.25 Scopolamine, a nonselective muscarinic antag-
onist block cholinergic signaling and produce memory and
cognitive dysfunctions and subsequently causes learning and
memory deficits including long-term and short term memory
impairments.26,27 It is thus implicated to exert amnesic effect
in rats and therefore an important rat model of cognition.28,29
In this study scopolamine induced dementia model assesses
memory function by the MWM and Y maze paradigms.tal cortices of rats: (A) and (B) normal and unaffected cytology of
ctions; (C) retraction of processes, vacuolation of the surrounding
mbrane into the perikaryal cytoplasm; (D) marked regeneration,
erikarya cytoplasm. (H&E 400).
Figure 5 Effects of scopolamine, BSO and Scop + BSO on the hippocampi CA1 of rats: (A) and (B) normal and unaffected cytology of
the small pyramidal neurons with well outlined soma and unaffected projections; (C) vacuolation in the surrounding neuropil of the
pyramidal cells, shrunken perikarya and blended membrane into the perikaryal cytoplasm. (D) Marked regeneration, reduced vacuolation
and neuropil spaces. (H&E  400).
Figure 6 Effects of scopolamine, BSO and Scop + BSO on the hippocampi CA3 of rats: (A) and (B) normal and unaffected cytology of
the large pyramidal neurons (CA3) with outlined soma and unaffected projections; (C) shrunken perikarya, blended membrane into the
perikaryal cytoplasm and glia activation. (D) Reduced vacuolation and distinct regenerations in the processes. (H&E 400).
Scopolamine-induced memory dysfunction and cortico-hippocampal neural alterations 53Scopolamine treatment delayed time of latency to find the hid-
den escape platform submerged in the water in the first and the
subsequent exposures after training, indicating impairment of
Long Term Memory (LTM) and Short Term Memory
(STM) respectively. BSO in this study improved
hippocampal-dependent memory tasks and was able to reversethe cognitive impairment induced by scopolamine by reducing
latency period, in both LTM and STM tasks in the MWM
paradigm.
These reported activities of BSO can be supported by vari-
ous workers who also reported BSO reduced escape latency,
distance traveled to reach the platform and increased time
Figure 7 Effects of scopolamine, BSO and Scop + BSO on the dentate gyrus of rats: (A) and (B) normal cytology of the dentate granule
cells with well outlined soma; (C) Dense eosinophilia of the granular cells, with hyperchromatic perykaryon. (D) Marked regeneration
with reduced hyperchromicity (H&E 400).
Figure 8 Effects of scopolamine, BSO and Scop + BSO on the Frontal cortices of rats: (A) and (B) normal nissl distributions in the
soma and unaffected proximal dendrites of the frontal pyramidal neuron (FC); (C) contrasting stains, pyknotic and darkly stained cell
body, presence of dark neurons (D) regeneration, reduced dark neurons (CFV 400).
54 A. Imam et al.spent in the target quadrant, in a MWM paradigm30 and
reversed cognitive and novel object recognition induced by
scopolamine.31 Also, the report of Bin Sayeed and colleagues
of the possible modulating impact of BSO on memory, atten-
tion, and cognition,32,33 memory improvement after scopo-
lamine induced amnesia34 and reversed memory impairment
observed in the MWM following pentylenetetrazole (PTZ) –induced repeated seizures in rats,35 further strengthened the
enhanced hippocampal dependent working memory observed
in the present study. BSO anti Alzheimer’s potential has been
reported to improve MWM test scores.36
Spontaneous alteration behavior (SAB) is a viable measure
of memory.37 BSO from this study significantly increased per-
centage alternation when given only and/or after scopolamine,
Figure 9 Effects of scopolamine, BSO and Scop + BSO on the hippocampi CA1 of rats: (A) and (B) normal and unaffected nissl
granulation in the mall pyramidal neuron (CA1); (C) pyknotic and darkly stained cell body, presence of dark neurons and vacuolation in
the surrounding neuropil; (D) reduced pyknoticity and disappearance of dark neurons (CFV 400).
Figure 10 Effects of scopolamine, BSO and Scop + BSO on the hippocampi CA3: (A) and (B) normal nissl granulation in the large
pyramidal neurons (CA3); (C) darkly stained cell body, vacuolation in the surrounding neuropil and shrunken perikarya; (D) marked
regeneration, less shrunken cells and contarasting soma stain (CFV 400).
Scopolamine-induced memory dysfunction and cortico-hippocampal neural alterations 55thus confirming its anti-amnesic efficacy and its nootropic
property. This effect is strengthened by the report of Rashid
and colleagues where a similar increase in percentage alterna-
tion was reported of thymoquinone, the active component of
BSO against scopolamine38 also its enhancing effect on spatial
working memory performance on the radial arm maze.39The observed effects of BSO in rescuing the deficits in hip-
pocampal neurons following scopolamine insults in the small
and large pyramidal cells of the CA1 and CA3 regions, and
the observed recovery in the dentate gyral granular cells
are strengthened by previous workers who reported that
BSO improved neuronal cell viability, protect against
Figure 11 Effects of scopolamine, BSO and Scop + BSO on the dentate gyrus of rats: (A) and (B) normal nissl granulation in the
granule cells; (C) pyknotic and darkly stained cell body; (D) marked regeneration, reduced vacuolation and distinct processes with less
blending in the perikarya cytoplasm (CFV 400).
56 A. Imam et al.beta-amyloid protein intoxication,40,41 protect against cerebral
ischemia reperfusion injury in the hippocampus,42 hippocam-
pal neurodegeneration42 and prevented hippocampal neuron
cell death in global cerebral ischemia.43 This study also evi-
denced the previous wide use of BSO in neurodegenerative dis-
eases like Parkinson and Alzheimer due to its antioxidant
potential,44–46 a property linked to the presence of thymo-
quinone which have the potential to prevent neuronal cell
death.47
5. Conclusion
In this study, black seed oil only improved percentage alterna-
tion, reduced escape latencies and ameliorated the delayed
latency induced by scopolamine but not alternation. It also
improved cortico-hippocampal granulation and histoarchitec-
ture. Hence, BSO could be a potential supplementary in the
managements of memory dysfunctions, due to its effects on
working memory, hippocampal dependent memory and
cortico-hippocampal neuron, against scopolamine induced
memory dysfunctions in rats. Exploring further its anti-
inflammatory, antioxidant and antiamnesic efficacy as a potent
novel supplements in neurodegenerative diseases.
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